These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
241 related items for PubMed ID: 9302370
1. Hydrocortisone replacement therapy in children and adolescents with hypopituitarism. DeVile CJ, Stanhope R. Clin Endocrinol (Oxf); 1997 Jul; 47(1):37-41. PubMed ID: 9302370 [Abstract] [Full Text] [Related]
2. The effect of growth hormone replacement therapy on adrenal androgen secretion in adult onset hypopituitarism. Isidori AM, Kaltsas GA, Perry L, Burrin JM, Besser GM, Monson JP. Clin Endocrinol (Oxf); 2003 May; 58(5):601-11. PubMed ID: 12699442 [Abstract] [Full Text] [Related]
4. Prolonged hypocortisolemia in hydrocortisone replacement regimens in adrenocorticotrophic hormone deficiency. Maguire AM, Ambler GR, Moore B, McLean M, Falleti MG, Cowell CT. Pediatrics; 2007 Jul; 120(1):e164-71. PubMed ID: 17576782 [Abstract] [Full Text] [Related]
5. Comparison of one week 0900 h serum cortisol, low and standard dose synacthen tests with a 4 to 6 week insulin hypoglycaemia test after pituitary surgery in assessing HPA axis. Courtney CH, McAllister AS, McCance DR, Bell PM, Hadden DR, Leslie H, Sheridan B, Atkinson AB. Clin Endocrinol (Oxf); 2000 Oct; 53(4):431-6. PubMed ID: 11012567 [Abstract] [Full Text] [Related]
6. Effect of glucocorticoid replacement therapy on glucose tolerance and intermediary metabolites in hypopituitary adults. al-Shoumer KA, Beshyah SA, Niththyananthan R, Johnston DG. Clin Endocrinol (Oxf); 1995 Jan; 42(1):85-90. PubMed ID: 7889636 [Abstract] [Full Text] [Related]
8. Overnight metabolic fuel deficiency in patients treated conventionally for hypopituitarism. Al-Shoumer KA, Ali K, Anyaoku V, Niththyananthan R, Johnston DG. Clin Endocrinol (Oxf); 1996 Aug; 45(2):171-8. PubMed ID: 8881449 [Abstract] [Full Text] [Related]
9. Bioavailability of oral hydrocortisone in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Charmandari E, Johnston A, Brook CG, Hindmarsh PC. J Endocrinol; 2001 Apr; 169(1):65-70. PubMed ID: 11250647 [Abstract] [Full Text] [Related]
10. Optimizing glucocorticoid replacement therapy in severely adrenocorticotropin-deficient hypopituitary male patients. Behan LA, Rogers B, Hannon MJ, O'Kelly P, Tormey W, Smith D, Thompson CJ, Agha A. Clin Endocrinol (Oxf); 2011 Oct; 75(4):505-13. PubMed ID: 21521342 [Abstract] [Full Text] [Related]
11. Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory? Charmandari E, Matthews DR, Johnston A, Brook CG, Hindmarsh PC. J Clin Endocrinol Metab; 2001 Oct; 86(10):4679-85. PubMed ID: 11600525 [Abstract] [Full Text] [Related]
12. Hydrocortisone replacement dosage influences intraocular pressure in patients with primary and secondary hypocortisolism. Li Voon Chong JS, Sen J, Johnson Z, Kyle G, MacFarlane IA. Clin Endocrinol (Oxf); 2001 Feb; 54(2):267-71. PubMed ID: 11207643 [Abstract] [Full Text] [Related]
13. The clinical utility of alternative, less invasive sampling techniques in the assessment of oral hydrocortisone therapy in children and adolescents with hypopituitarism. Maguire AM, Ambler GR, Moore B, Waite K, McLean M, Cowell CT. Eur J Endocrinol; 2007 Apr; 156(4):471-6. PubMed ID: 17389462 [Abstract] [Full Text] [Related]
14. Oral hydrocortisone administration in children with classic 21-hydroxylase deficiency leads to more synchronous joint GH and cortisol secretion. Charmandari E, Pincus SM, Matthews DR, Johnston A, Brook CG, Hindmarsh PC. J Clin Endocrinol Metab; 2002 May; 87(5):2238-44. PubMed ID: 11994370 [Abstract] [Full Text] [Related]
15. Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: a pharmacokinetic study. Johannsson G, Bergthorsdottir R, Nilsson AG, Lennernas H, Hedner T, Skrtic S. Eur J Endocrinol; 2009 Jul; 161(1):119-30. PubMed ID: 19383806 [Abstract] [Full Text] [Related]
16. Growth hormone treatment in hypopituitary GH deficient adults reduces circulating cortisol levels during hydrocortisone replacement therapy. Rodríguez-Arnao J, Perry L, Besser GM, Ross RJ. Clin Endocrinol (Oxf); 1996 Jul; 45(1):33-7. PubMed ID: 8796136 [Abstract] [Full Text] [Related]
17. Effects of low-dose oral hydrocortisone replacement versus short-term reproduction of physiological serum cortisol concentrations on insulin action in adult-onset hypopituitarism. McConnell EM, Bell PM, Ennis C, Hadden DR, McCance DR, Sheridan B, Atkinson AB. Clin Endocrinol (Oxf); 2002 Feb; 56(2):195-201. PubMed ID: 11874410 [Abstract] [Full Text] [Related]
19. Glucocorticoid replacement therapy: are patients over treated and does it matter? Peacey SR, Guo CY, Robinson AM, Price A, Giles MA, Eastell R, Weetman AP. Clin Endocrinol (Oxf); 1997 Mar; 46(3):255-61. PubMed ID: 9156031 [Abstract] [Full Text] [Related]
20. Early morning cortisol levels as predictors of short-term and long-term adrenal function after endonasal transsphenoidal surgery for pituitary adenomas and Rathke's cleft cysts. McLaughlin N, Cohan P, Barnett P, Eisenberg A, Chaloner C, Kelly DF. World Neurosurg; 2013 Nov; 80(5):569-75. PubMed ID: 22902358 [Abstract] [Full Text] [Related] Page: [Next] [New Search]